Unaudited financial results of China Medical Technologies to be announced on September 1, 2009

NewsGuard 100/100 Score

China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial results for the fourth fiscal quarter ("4Q FY2008") and fiscal year ended March 31, 2009 ("FY2008") and the first fiscal quarter ("1Q FY2009") ended June 30, 2009 before the U.S. market opens on September 1, 2009. The Company's 2009 fiscal year ends on March 31, 2010.

The Company's CEO, Mr. Xiaodong Wu, and CFO, Mr. Sam Tsang, will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on September 1, 2009 (8:00 p.m. on September 1, 2009 Beijing/Hong Kong time).

Conference Call The dial-in details for the live conference call are as follows: -- U.S. Toll Free Number 1-800-291-9234 -- International Dial-in Number 1-617-614-3923 Passcode: CMEDCALL

A live webcast of the conference call will be available on http://ir.chinameditech.com .

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on September 2, 2009. The dial-in details for the replay are as follows:

-- U.S. Toll Free Number 1-888-286-8010 -- International Dial-in Number 1-617-801-6888 Passcode: 92901366

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases